Vividion Therapeutics Company

Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.
Investors
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
San Diego, California, United States
Founded Date:
2013
Employees Number:
101-250
Funding Status:
Late Stage Venture
Investors Number:
12
Total Funding:
$236.5M
Estimated Revenue:
$50M to $100M
Last Funding Type:
Series B
Register and Claim Ownership